United States Government Publishing Office
publisher
pbl
distributor
dst
United States
National Archives and Records Administration
Office of the Federal Register
author
aut
Government Organization
text
government publication
eng
FR
Regulatory Information
2009_register
executive
2009-03-31
article
Developing a Consolidated Pediatric Rheumatology Observational Registry; Public Workshop
Notices
D09002ee1bdd78131
D09002ee1bdd781c7
United States
Department of Health and Human Services
originator
org
United States Government Agency or Subagency
United States
Food and Drug Administration
originator
org
United States Government Agency or Subagency
The Food and Drug Administration (FDA) is announcing a public workshop entitled ``Developing a Consolidated Pediatric Rheumatology Observational Registry.'' This 2-day public workshop is intended to seek constructive input from key stakeholders in the pediatric rheumatology community, the pharmaceutical industry and the public to explore the value and feasibility of developing a consolidated pediatric rheumatology observational registry.
74 FR 13215
https://www.govinfo.gov/app/details/FR-2009-03-26/E9-6709
E9-6709
FR26MR09-79
4160-01-S
Docket No. FDA-2009-N-0145
https://www.govinfo.gov/app/details/FR-2009-03-26/E9-6709
https://www.govinfo.gov/content/pkg/FR-2009-03-26/html/E9-6709.htm
https://www.govinfo.gov/content/pkg/FR-2009-03-26/pdf/E9-6709.pdf
2 p.
13215
13216
74 FR 13215
Developing a Consolidated Pediatric Rheumatology Observational Registry; Public Workshop; Federal Register Vol. 74, Issue
NOTICE
E9-6709
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
2009-07-14
Docket No. FDA-2009-N-0145
4160-01-S
E9-6709
Notice of public workshop; request for comments.
The Food and Drug Administration (FDA) is announcing a public workshop entitled ``Developing a Consolidated Pediatric Rheumatology Observational Registry.'' This 2-day public workshop is intended to seek constructive input from key stakeholders in the pediatric rheumatology community, the pharmaceutical industry and the public to explore the value and feasibility of developing a consolidated pediatric rheumatology observational registry.
The public workshop will be held on May 12, 2009, from 8:30 a.m. to 5 p.m. and on May 13, 2009, from 8:30 a.m. to noon. Register by April 21, 2009, to make a presentation at the workshop. See section III of this document for information on how to attend or present at the workshop. We are opening a docket to receive your written or electronic comments. Written or electronic comments must be submitted to the docket by July 14, 2009.
Diane Ehrlich, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 51, rm. 6190, Silver Spring, MD 20993-0002, 301- 796-3452, FAX: 301-847-8753, e-mail: Diane.Ehrlich@fda.hhs.gov.
Public Workshop:
Developing a Consolidated Pediatric Rheumatology Observational Registry
,
Diane.Ehrlich@fda.hhs.gov
http://www.regulations.gov
Federal Register
Vol. 74, no. 57
Office of the Federal Register, National Archives and Records Administration
2009-03-26
continuing
daily
deposited
born digital
270 p.
Table of Contents:
AE 2.7:
GS 4.107:
AE 2.106:
KF70.A2
https://www.govinfo.gov/app/details/FR-2009-03-26
P0b002ee180088085
0097-6326
0042-1219
0364-1406
769-004-00000-9
000582072
f:FR26MR09
https://www.govinfo.gov/app/details/FR-2009-03-26
https://www.govinfo.gov/content/pkg/FR-2009-03-26/pdf/FR-2009-03-26.pdf
https://www.govinfo.gov/content/pkg/FR-2009-03-26/xml/FR-2009-03-26.xml
fdlp
13055
13312
DGPO
2009-03-31
2023-05-02
FR-2009-03-26
machine generated
eng
FR
FR-2009-03-26
74
57